Robert J. Moots

15.5k total citations · 3 hit papers
176 papers, 8.2k citations indexed

About

Robert J. Moots is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Robert J. Moots has authored 176 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Rheumatology, 65 papers in Immunology and 23 papers in Hematology. Recurrent topics in Robert J. Moots's work include Rheumatoid Arthritis Research and Therapies (64 papers), Systemic Lupus Erythematosus Research (28 papers) and Autoimmune and Inflammatory Disorders Research (22 papers). Robert J. Moots is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (64 papers), Systemic Lupus Erythematosus Research (28 papers) and Autoimmune and Inflammatory Disorders Research (22 papers). Robert J. Moots collaborates with scholars based in United Kingdom, United States and Italy. Robert J. Moots's co-authors include Steven W. Edwards, Helen L. Wright, R C Bucknall, Andrew Cross, Raashid Luqmani, P A Bacon, Sizheng Steven Zhao, Theresa Barnes, P. Emery and Caroline O.S. Savage and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Robert J. Moots

165 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

1994 851 citations Raashid Luqmani, P A Bacon et al. profile →
Neutrophil function in inflammation and inflammatory diseases

2010 598 citations Helen L. Wright, Robert J. Moots et al. Lara D. Veeken profile →
The multifactorial role of neutrophils in rheumatoid arthritis

2014 445 citations Helen L. Wright, Robert J. Moots et al. profile →

Peers

Countries citing papers authored by Robert J. Moots

Since Specialization

Citations

This map shows the geographic impact of Robert J. Moots's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Moots with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Moots more than expected).

Fields of papers citing papers by Robert J. Moots

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Moots. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Moots. The network helps show where Robert J. Moots may publish in the future.

Co-authorship network of co-authors of Robert J. Moots

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Moots. A scholar is included among the top collaborators of Robert J. Moots based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Moots. Robert J. Moots is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trial 2024 ·Osteoarthritis and Cartilage ·Asger Reinstrup Bihlet, I. Byrjalsen, J.R. Andersen, Alan Reynolds, (unknown), Peter Alexandersen, (unknown), Robert J. Moots, Philip G. Conaghan	7
2	What benefit–risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment 2024 ·RMD Open ·Rieke Alten, Juan Carlos Nieto‐González, Peggy Jacques, Carlomaurizio Montecucco, Robert J. Moots, Helga Radner, Harald E. Vonkeman, Sebastian Heidenreich, Chiara Whichello, Nicolas Krucien, Katrien Van Beneden	0
3	Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial 2024 ·Lara D. Veeken ·Robert J. Moots, Farida Fortune, Richard Jackson, (unknown), Ann W Morgan, Daniel F. Carr, Philip I. Murray, Graham R. Wallace, Deva Situnayake	4
4	Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study 2024 ·Arthritis & Rheumatology ·Thomas Dörner, Simon Bowman, Robert I. Fox, Xavier Mariette, Athena Papas, Thomas Grader‐Beck, Benjamin A. Fisher, Filipe Barcelos, Salvatore De Vita, Hendrik Schulze‐Koops, Robert J. Moots, G. Junge, (unknown), Monika Sopala, Alexandre Avraméas, Wen‐Lin Luo, Wolfgang Hueber	3
5	Patients with High Baseline Neutrophil-to-Lymphocyte Ratio Exhibit Better Response to Filgotinib as Treatment for Rheumatoid Arthritis 2024 ·Rheumatology and Therapy ·Peter C. Taylor, Bryan Downie, (unknown), Rachael E. Hawtin, (unknown), Robert J. Moots, Tsutomu Takeuchi	0
6	Influencers of Achievement of Remission and Low Disease Activity in Response to Disease-Modifying Antirheumatic Drugs (DMARDs) in Patients With Rheumatoid Arthritis 2024 ·Cureus ·(unknown), Anastasia N Guantai, Robert J. Moots, Faith Okalebo, (unknown)	1
7	Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression 2020 ·Clinical & Experimental Immunology ·(unknown), Robert J. Moots, Steven W. Edwards, Helen L. Wright	27
8	Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus 2019 ·Frontiers in Immunology ·Elinor Chapman, Max Lyon, Deborah M. Simpson, David Y. Mason, Robert J. Beynon, Robert J. Moots, Helen L. Wright	152
9	Mycophenolate for persistent complex regional pain syndrome, a parallel, open, randomised, proof of concept trial 2018 ·Scandinavian Journal of Pain ·Andreas Göebel, Anu Jacob, Bernhard Frank, Paul Sacco, Guillermo M. Alexander, (unknown), Paul Bassett, Robert J. Moots	13
10	Impact of Obesity on 1 Year Outcomes: Results from the Meteor Foundation International Rheumatoid Arthritis Cohort 2014 ·Data Archiving and Networked Services (DANS) ·(unknown), Robert J. Moots, Eftychia Eirini Psarelli, T. Huizinga, Nicola Goodson	2
11	Neutrophil-derived reactive oxygen species in SSc 2012 ·Lara D. Veeken ·T. Cunliffe Barnes, Marina Anderson, Steven W. Edwards, Robert J. Moots	44
12	The role of neutrophil apoptosis in juvenile‐onset systemic lupus erythematosus 2009 ·Arthritis & Rheumatism ·Angela Midgley, Zoe McLaren, Robert J. Moots, Steven W. Edwards, Michael W. Beresford	69
13	Sodium Salicylate Promotes Neutrophil Apoptosis by Stimulating Caspase-Dependent Turnover of Mcl-1 2006 ·The Journal of Immunology ·Mathieu Derouet, Luke W. Thomas, Dale Moulding, (unknown), Andrew Cross, Robert J. Moots, Steven W. Edwards	49
14	Rheumatoid arthritis - treatment [112-148] 2005 ·British journal of rheumatology ·(unknown), Robert J. Moots, Julie Dawson, R. N. Thompson, (unknown), L Pazmany, (unknown), (unknown), Rainer Döffinger, F. Scott Hall, Andrew Kean Seng Lim, Karl Gaffney, David G. I. Scott, (unknown), (unknown), Chris Deighton, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
15	The Mitochondrial Network of Human Neutrophils: Role in Chemotaxis, Phagocytosis, Respiratory Burst Activation, and Commitment to Apoptosis 2003 ·The Journal of Immunology ·Gianluca Fossati, Dale Moulding, David G. Spiller, Robert J. Moots, Michael White, Steven W. Edwards	284
16	Vasculitis integrated total assessment log (VITAL): A system for clinical evaluation of vasculitis. 1996 ·Oxford University Research Archive (ORA) (University of Oxford) ·Raashid Luqmani, (unknown), (unknown), (unknown), George D. Kitas, Andrew Exley, Robert J. Moots, P A Bacon	6
17	THE VASCULITIS DAMAGE INDEX (VDI) 1995 ·Oxford University Research Archive (ORA) (University of Oxford) ·Andrew Exley, (unknown), (unknown), Robert J. Moots, Raashid Luqmani, George D. Kitas, Paul Bacon	3
18	FUNCTIONAL ASSESSMENT IN VASCULITIS USING THE SF-36 1995 ·Oxford University Research Archive (ORA) (University of Oxford) ·Andrew Exley, Robert J. Moots, (unknown), Raashid Luqmani, P A Bacon	1
19	Liver disease in twins with Felty's syndrome. 1994 ·Annals of the Rheumatic Diseases ·Robert J. Moots, Elwyn Elias, (unknown), M Salmon, P. Emery	4
20	CONTROLLED TRIAL OF PULSE VS CONTINUOUS CYCLOPHOSPHAMIDE (CY) AND PREDNISOLONE (P) IN THE TREATMENT OF SYSTEMIC VASCULITIS 1993 ·Oxford University Research Archive (ORA) (University of Oxford) ·Raashid Luqmani, Abeed A. Pall, D. Adu, Robert J. Moots, Nicholas T. Richards, A. J. Howie, (unknown), P. Emery, P A Bacon	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact